Dermavir (DER) ICO Details & Financial Information

More Info About ICO

ICO NameDermavir
Start DateTBA
End DateTBA

Genetic Immunity is a US clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of therapeutic vaccines ("Immune Therapies") for the treatment of chronic viral infections (HIV, HPV), cancer and allergies. Our Immune Therapies are designed to intensify and boost specific immune response to modify or control these presently incurable diseases. We believe our products will allow people to live better, healthier and longer lives.

Chief Executive Officer
Chief Operations Officer
Price1.00 USDSale10,000,000Payment ModeETH
Minimum Investment0.1 ETHDistribution50%RaisedUnknown
Soft CapN/AHard Cap10 000 000 DER